Literature DB >> 7572781

Traditional Chinese medicines improve the course of refractory leukemic lymphoblastic lymphoma and acute lymphocytic leukemia: two case reports.

Y Hijikata1, J Kaneko, L Xi, M Nasu, S Yamashita.   

Abstract

A 34 year-old man with leukemic lymphoblastic lymphoma (LBL), who could not tolerate chemotherapy due to its side effects, was diagnosed to have an acute febrile disease by a traditional Chinese medical doctor, Lu Gan Fu. Zixuedan, a traditional Chinese remedy for dissipation of pathogenic heat and detoxification that could reduce WBC count including leukemic cells below 1000/microliters without intolerable side effects, was prescribed for treatment. A second case of acute lymphocytic leukemia (ALL) was a 41 year-old female who also could not tolerate chemotherapy. In her fourth recurrence, she started Chinese medicine including modified zixuedan, which gave her transient improvement followed by aggravation. Intake of previously ineffective cyclophosphamide in combination with Chinese medicine led to a dramatic improvement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572781     DOI: 10.1142/S0192415X95000250

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  Treatment for intractable anemia with the traditional Chinese medicines Hominis Placenta and Cervi Cornus Colla (deer antler glue).

Authors:  Yasuyo Hijikata; Takashi Kano; Lu Xi
Journal:  Int J Gen Med       Date:  2009-07-30

2.  Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation.

Authors:  Qian Huang; Jinkun Lin; Surong Huang; Jianzhen Shen
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.